Polymeric perfluoroalkylether-linked quinoxalines
Abstract
Perfluoroalkylether-linked quinoxalines having repeating units of the formula: ##STR1## wherein R f is selected from the group consisting of --OCF 2 CF 2 --, --OCF 2 CF 2 CF 2 --, --OCF 2 CF 2 CF 2 CF 2 --, --OCF 2 CF(CF 3 )-- and --OCF 2 CF 2 OCF 2 CF(CF 3 )--; wherein n has a value of 2 to 4, and m has a value of 1 to 20; and wherein R is a single bond, --O--, --S--, --C 6 H 4 --O--C 6 H 4 --, or --SO 2 --, are prepared by the steps of (a) preparing a perfluoroalkylether diiodide of the formula I(CF 2 ) n (R f ) m (CF 2 ) n l; (b) reacting the perfluoroalkylether diiodide with 4-iodobenzil to produce the tetraketone C 6 H 5 C(O)C(O)C 6 H 4 (CF 2 ) n (R f ) m (CF 2 ) n C 6 H 4 C(O)C(O)C 6 H 5 ; and (c) reacting the resulting tetraketone with a tetraamine of the formula ##STR2## wherein R is a single bond, --O--, --S--, --C 6 H 4 O--C 6 H 4 --, or --SO 2 --. The perfluoroalkylether-linked quinoxalines can be end-capped with, for example, a low proportion of co-monomers having crosslinking sites such as acetylenic linkages to allow for crosslinking and chain extension on curing.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A process for preparing a perfluoroalkylether-linked quinoxaline having repeating units of the formula: ##STR7## wherein R f is selected from the group consisting of --OCF 2 CF 2 --, --OCF 2 CF 2 CF 2 --, --OCF 2 CF 2 CF 2 CF 2 --, --OCF 2 CF(CF 3 )-- and --OCF 2 CF 2 OCF 2 CF(CF 3 )--; wherein n has a value of 2 to 4, and m has a value of 1 to 20; and wherein R is a single bond, --O--, --S--, --C 6 H 4 O--C 6 H 4 --, or --SO 2 --, which comprises the steps of: (a) preparing a perfluoroalkylether diiodide of the formula I(CF 2 ) n (R f ) m (CF 2 ) n I; (b) reacting the perfluoroalkylether diiodide with 4-iodobenzil to produce the tetraketone C 6 H 5 C(O)C(O)C 6 H 4 (CF 2 ) n (R f ) m (CF 2 ) n C 6 H 4 C(O)C(O)C 6 H 5 ; and (c) reacting the resulting tetraketone with a tetraamine of the formula ##STR8## wherein R is as defined above.
2. The process of claim 1 wherein R is a single bond, n is 3, R f is --OC 4 F 8 and m is 2.
3. The process of claim 1 further comprising the step of (d) end-capping the reaction product of step (c) .
4. The process of claim 3 wherein an excess of said tetraketone is employed in step (c) and wherein the resulting reaction product is end-capped with 1,2-phenylenediamine to provide a polymer of the formula ##STR9## wherein R f ' is --(CF 2 ) n (R f ) m O(CF 2 ) n --, wherein n is 3, R f is --OC 4 F 8 -- and m is 2, and x has a value between 3 and 50.
5. The process of claim 4 wherein R is a single bond, R f ' is --(CF 2 ) 3 O(C 4 F 8 O) 2 (CF 2 ) 3 -- and x is 3.7.
6. The process of claim 4 wherein R is a single bond, R f ' is --(CF 2 ) 3 O(C 4 F 8 O) 2 (CF 2 ) 3 -- and x is 10.0.
7. A perfluoroalkylether-linked quinoxaline having repeating units of the formula: ##STR10## wherein R f is selected from the group consisting of --OCF 2 CF 2 --, --OCF 2 CF 2 CF 2 --, --OCF 2 CF 2 CF 2 CF 2 --, --OCF 2 CF(CF 3 )-- and --OCF 2 CF 2 OCF 2 CF(CF 3 )--; wherein n has a value of 2 to 4, and m has a value of 1 to 20; and wherein R is a single bond, --O--, --S--, --C 6 H 4 --O--C 6 H 4 --, or ---SO 2 --.
8. The perfluoroalkylether-linked quinoxaline of claim 7 wherein R is a single bond, n is 3, R f is ---OC 4 F 8 -- and m is 2.
9. The perfluoroalkylether-linked quinoxaline of claim 8 wherein the average number of repeating units is 3.7.
10. The perfluoroalkylether-linked quinoxaline of claim 8 wherein the average number of repeating units is 10.0.
11. The tetraketone C 6 H 5 C(O)C(O)C 6 H 4 (CF 2 ) n (R f ) m (CF 2 ) n C 6 H 4 C(O)C(O)C 6 H 5 wherein R f is selected from the group consisting of --OCF 2 CF 2 --, --OCF 2 CF 2 CF 2 --, --OCF 2 CF 2 CF 2 CF 2 --, --OCF 2 CF(CF 3 )-- and --OCF 2 CF 2 OCF 2 CF(CF 3 )--; wherein n has a value of 2 to 4; and wherein m has a value of 1 to 20.
12. The tetraketone of claim 11 wherein n is 3, R f is --OC 4 F 8 -- and m is 2.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.